Hysbysiad dyfarnu contract
Canlyniadau'r weithdrefn gaffael
Adran I:
Endid
contractio
I.1) Enw a chyfeiriad
NHS Blood & Transplant
500-600 North Bristol Park, Northway Bristol, Filton
BRISTOL
BS347QH
UK
Person cyswllt: Marta Drozdzowska
Ffôn: +44 1179217243
E-bost: marta.drozdzowska@nhsbt.nhs.uk
NUTS: UK
Cyfeiriad(au) rhyngrwyd
Prif gyfeiriad: https://www.nhsbt.nhs.uk/
I.4) Y math o awdurdod contractio
Corff a lywodraethir gan gyfraith gyhoeddus
I.5) Prif weithgaredd
Iechyd
Adran II: Gwrthrych
II.1) Cwmpas y caffaeliad
II.1.1) Teitl
Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis
Cyfeirnod: NHSBT1498 / C39526
II.1.2) Prif god CPV
33140000
II.1.3) Y math o gontract
Cyflenwadau
II.1.4) Disgrifiad byr
The award is for Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis.
Contract notice published on 10th March 2021 with publication reference: 2021/S 000-004887.
Please see section II.2.4 for detailed description of the procurement.
II.1.6) Gwybodaeth am lotiau
Mae’r contract hwn wedi’i rannu’n lotiau:
Na
II.1.7) Cyfanswm gwerth y caffaeliad
Gwerth heb gynnwys TAW: 99 500.00 GBP
II.2) Disgrifiad
II.2.2) Cod(au) CPV ychwanegol
33693000
50421000
II.2.3) Man cyflawni
Cod NUTS:
UK
II.2.4) Disgrifiad o’r caffaeliad
The Therapeutic Apheresis Services (TAS) function operates within the Clinical Services directorate of NHSBT. Multi-disciplinary TAS teams operate from eight regional hub units and three 3 spoke sites that are based within Acute NHS Trusts across England and South Wales. Each unit provides a portfolio of therapeutic treatments to both adult and paediatric patients from across a range of clinical specialities. Treatments provided include: Extracorporeal Photopheresis (ECP), Peripheral Blood Stem Cell (PBSC) Collection, Therapeutic Plasma Exchange (PEX), Red Cell Exchange (RCE), Low Density Lipid (LDL) Removal, Platelet / White Cell Depletion and Lymphocyte Collection.
The requirement for this procurement was for the supply of consumables and maintenance of the existing ART Universal machines. Contract notice published on 10th March 2021 with publication reference: 2021/S 000-004887.
As a result of the tender, a Framework Agreement for Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis for a period of 2 years with two 1-year options to extend has been awarded to Fresenius Medical Care (UK) Ltd.
II.2.5) Meini prawf dyfarnu
Price
II.2.11) Gwybodaeth am opsiynau
Opsiynau:
Na
II.2.13) Gwybodaeth am Gronfeydd yr Undeb Ewropeaidd
Mae'r broses gaffael yn gysylltiedig â phrosiect a/neu raglen a ariennir gan gronfeydd yr Undeb Ewropeaidd:
Na
Section IV: Gweithdrefn
IV.1) Disgrifiad
IV.1.1) Y math o weithdrefn
Gweithdrefn agored
IV.1.8) Gwybodaeth am Gytundeb Caffael y Llywodraeth (GPA)
The procurement is covered by the Government Procurement Agreement:
Ydy
IV.2) Gwybodaeth weinyddol
IV.2.1) Cyhoeddiad blaenorol mewn perthynas â’r weithdrefn hon
Rhif yr hysbysiad yn OJ S:
2020/S 230-568414
Section V: Dyfarnu contract
Rhif Contract: NHSBT1498 / C39526
Teitl: Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis
Dyfernir contract/lot:
Ydy
V.2 Dyfarnu contract
V.2.1) Y dyddiad y daeth y contract i ben
01/08/2021
V.2.2) Gwybodaeth am dendrau
Nifer y tendrau a ddaeth i law: 1
Dyfarnwyd y contract i gr?p o weithredwyr economaidd:
Na
V.2.3) Enw a chyfeiriad y contractwr
Fresenius Medical Care (UK) Ltd
Sutton-in-Ashfield
NG17 2HU
UK
NUTS: UK
BBaCh yw’r contractwr:
Na
V.2.4) Gwybodaeth am werth y contract/lot (heb gynnwys VAT)
Cyfanswm gwerth y contract/lot: 99 500.00 GBP
V.2.5) Gwybodaeth am is-gontractio
Section VI: Gwybodaeth ategol
VI.4) Gweithdrefnau adolygu
VI.4.1) Corff adolygu
NHS Blood and Transplant
Bristol
UK
VI.5) Dyddiad anfon yr hysbysiad hwn
11/08/2021